HROW (STOCKS)
Harrow, Inc. Common Stock
$38.870000
-0.490000 (-1.24%)
Prev close: $39.360000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mark L. Baum
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,465.71M
- Employees
- 382
- P/E (TTM)
- -39.38
- P/B (TTM)
- 97.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.34 | $-0.18 | -0.1564 | -85.19% |
|
Mar 2026 (Q1)
|
$-0.74 | $-0.41 | -0.3305 | -80.71% |
|
Dec 2025 (Q4)
|
$0.17 | $0.38 | -0.2061 | -54.80% |
|
Sep 2025 (Q3)
|
$0.22 | $0.27 | -0.0487 | -18.12% |
Financial Statements
| Revenues | $275.59M |
| Benefits Costs and Expenses | $309.02M |
| Cost Of Revenue | $73.64M |
| Costs And Expenses | $309.02M |
| Gross Profit | $201.96M |
| Operating Expenses | $204.71M |
| Selling, General, and Administrative Expenses | $175.69M |
| Depreciation and Amortization | $1.87M |
| Research and Development | $29.01M |
| Operating Income/Loss | -$2.75M |
| Income/Loss From Continuing Operations After Tax | -$37.20M |
| Income/Loss From Continuing Operations Before Tax | -$33.43M |
| Income Tax Expense/Benefit | $3.80M |
| Net Income/Loss | -$37.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$37.23M |
| Net Income/Loss Available To Common Stockholders, Basic | -$37.23M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.99 |
| Diluted Earnings Per Share | -$0.99 |
| Basic Average Shares | 74,608,928 |
| Diluted Average Shares | 113,629,025 |
| Assets | $416.82M |
| Current Assets | $229.31M |
| Inventory | $16.91M |
| Other Current Assets | $212.40M |
| Noncurrent Assets | $187.51M |
| Fixed Assets | $2.96M |
| Intangible Assets | $175.57M |
| Other Non-current Assets | $8.98M |
| Liabilities | $401.97M |
| Current Liabilities | $102.17M |
| Accounts Payable | $26.27M |
| Wages | $11.58M |
| Other Current Liabilities | $64.33M |
| Noncurrent Liabilities | $299.80M |
| Equity | $14.85M |
| Equity Attributable To Noncontrolling Interest | -$355.00K |
| Equity Attributable To Parent | $15.20M |
| Liabilities And Equity | $416.82M |
| Net Cash Flow From Operating Activities | $6.25M |
| Net Cash Flow From Operating Activities, Continuing | $6.25M |
| Net Cash Flow From Investing Activities | -$23.69M |
| Net Cash Flow From Investing Activities, Continuing | -$23.69M |
| Net Cash Flow From Financing Activities | $48.37M |
| Net Cash Flow From Financing Activities, Continuing | $48.37M |
| Net Cash Flow | $30.93M |
| Net Cash Flow, Continuing | $30.93M |
| Comprehensive Income/Loss | -$37.23M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$37.23M |
| Other Comprehensive Income/Loss | $0.00 |